|
Index of reports
> Cases with Completed Suicide ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vyvanse (Lisdexamfetamine) where reactions include completed suicide. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vyvanse side effects in 10 year old female
Reported by a consumer/non-health professional from United States on 2012-02-17
Patient: 10 year old female, weighing 45.4 kg (99.8 pounds)
Reactions: Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in 10 year old female
Reported by a consumer/non-health professional from United States on 2012-02-08
Patient: 10 year old female
Reactions: Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-12
Patient: 10 year old female
Reactions: Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in 16 year old male
Reported by a consumer/non-health professional from United States on 2011-11-10
Patient: 16 year old male
Reactions: Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-27
Patient: female
Reactions: Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Vyvanse
Possible Vyvanse side effects in 7 year old male
Reported by a physician from United States on 2011-10-06
Patient: 7 year old male, weighing 30.4 kg (66.9 pounds)
Reactions: Completed Suicide, Abnormal Behaviour, Impulsive Behaviour, Aggression
Adverse event resulted in: death
Drug(s) suspected as cause:
Symbyax
Dosage: 3mg/25mg (1 in 1 d),
Indication: Aggression
Start date: 2009-03-18
End date: 2009-04-16
Symbyax
Dosage: 3mg/25mg (1 in 1 d),
Indication: Impulsive Behaviour
Start date: 2009-03-18
End date: 2009-04-16
Lexapro
Dosage: 5 mg (5 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Anxiety
Start date: 2009-02-03
End date: 2009-03-18
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Affective Disorder
Start date: 2009-03-31
End date: 2009-04-16
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Start date: 2009-03-31
End date: 2009-04-16
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Affective Disorder
Start date: 2008-12-09
End date: 2009-03-30
Vyvanse
Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Attention Deficit / Hyperactivity Disorder
Start date: 2008-12-09
End date: 2009-03-30
|
